FI93835B - Menetelmä 3-(bentsotiatsol-2-yylimetyyli)-4-okso-3-H-ftaaliatsin-1-yylietikkahappojohdannaisten valmistamiseksi - Google Patents

Menetelmä 3-(bentsotiatsol-2-yylimetyyli)-4-okso-3-H-ftaaliatsin-1-yylietikkahappojohdannaisten valmistamiseksi

Info

Publication number: FI93835B
Authority: FI; Finland
Prior art keywords: preparation; phthalazin; benzothiazol; ylmethyl; oxo
Prior art date: 1987-06-09

Application number

FI882722A

Other languages

English (en)

Swedish (sv)

Other versions

FI882722A0 (fi

FI93835C (fi

FI882722A (fi

Inventor

Banavara Lakshmana Mylari

William James Zembrowski

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-09

Filing date

1988-06-08

Publication date

1995-02-28

1988-06-08 Application filed by Pfizer filed Critical Pfizer

1988-06-08 Publication of FI882722A0 publication Critical patent/FI882722A0/fi

1988-12-10 Publication of FI882722A publication Critical patent/FI882722A/fi

1995-02-28 Application granted granted Critical

1995-02-28 Publication of FI93835B publication Critical patent/FI93835B/fi

1995-06-12 Publication of FI93835C publication Critical patent/FI93835C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Thiazole And Isothizaole Compounds (AREA)

FI882722A 1987-06-09 1988-06-08 Menetelmä 3-(bentsotiatsol-2-yylimetyyli)-4-okso-3-H-ftaaliatsin-1-yylietikkahappojohdannaisten valmistamiseksi FI93835C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5989987A	1987-06-09	1987-06-09
US5989987		1987-06-09

Publications (4)

Publication Number	Publication Date
FI882722A0 FI882722A0 (fi)	1988-06-08
FI882722A FI882722A (fi)	1988-12-10
FI93835B true FI93835B (fi)	1995-02-28
FI93835C FI93835C (fi)	1995-06-12

Family

ID=22026001

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI882722A FI93835C (fi)	1987-06-09	1988-06-08	Menetelmä 3-(bentsotiatsol-2-yylimetyyli)-4-okso-3-H-ftaaliatsin-1-yylietikkahappojohdannaisten valmistamiseksi

Country Status (26)

Country	Link
EP (1)	EP0295051B1 (fi)
JP (1)	JPH0676391B2 (fi)
KR (1)	KR900004698B1 (fi)
CN (1)	CN1024347C (fi)
AT (1)	ATE90347T1 (fi)
AU (1)	AU593742B2 (fi)
CA (1)	CA1321791C (fi)
CS (1)	CS274628B2 (fi)
DD (3)	DD280323A5 (fi)
DE (1)	DE3881583T2 (fi)
DK (1)	DK309988A (fi)
EG (1)	EG18613A (fi)
ES (1)	ES2040853T3 (fi)
FI (1)	FI93835C (fi)
HU (1)	HU205108B (fi)
IE (1)	IE61499B1 (fi)
IL (1)	IL86660A0 (fi)
MY (1)	MY103573A (fi)
NO (1)	NO176317C (fi)
NZ (1)	NZ224937A (fi)
PH (1)	PH25928A (fi)
PL (1)	PL157690B1 (fi)
PT (1)	PT87669B (fi)
SU (1)	SU1678208A3 (fi)
YU (1)	YU46696B (fi)
ZA (1)	ZA884075B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0322153A3 (en) *	1987-12-21	1990-08-16	Pfizer Inc.	Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) *	1988-01-19	1989-07-27	Pfizer Inc.	1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) *	1988-02-29	1990-02-27	Pfizer Inc.	Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) *	1989-05-11	1990-09-04	Pfizer Inc.	Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) *	1989-06-05	1990-12-07	Union Pharma Scient Appl	Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US5304557A (en) *	1989-12-15	1994-04-19	Pfizer Inc.	Substituted oxoophthalazinyl acetic acids and analogs thereof
US5064830A (en) *	1990-08-02	1991-11-12	Pfizer Inc.	Lowering of blood uric acid levels
WO1992003432A1 (en) *	1990-08-28	1992-03-05	Pfizer Inc.	3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
DE9290035U1 (de) *	1991-03-28	1993-11-18	Pfizer Inc., New York, N.Y.	Pyridazinonessigsäuren
FR2682108B1 (fr) *	1991-10-07	1994-01-07	Lipha	Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
EP0652213B1 (en) *	1993-10-06	1997-08-27	SUMIKA FINE CHEMICALS Co., Ltd.	Method for producing alkyl 3-phthalidylideneacetate
US5700819A (en) *	1994-11-29	1997-12-23	Grelan Pharmaceutical Co., Ltd.	2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) *	1997-05-05	2003-01-12	Pfizer	Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) *	1998-08-21	2000-07-05	Pfizer Products Inc.	Polymorph of zopolrestat monohydrate
SG82702A1 (en) *	1999-09-28	2001-08-21	Ebauchesfabrik Eta Ag	Timepiece including a movement mounted in a casing ring
CN116970317B (zh) *	2023-03-20	2024-06-25	安徽庆丰涂料科技有限公司	可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE47592B1 (en) *	1977-12-29	1984-05-02	Ici Ltd	Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) *	1979-06-06	1984-08-02	昭和電工株式会社	３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
DE3684410D1 (de) *	1985-11-07	1992-04-23	Pfizer	Heterocyclische oxophthalazinylessigsaeure.

1988
- 1988-06-02 JP JP63136601A patent/JPH0676391B2/ja not_active Expired - Lifetime
- 1988-06-06 MY MYPI88000606A patent/MY103573A/en unknown
- 1988-06-06 PH PH37013A patent/PH25928A/en unknown
- 1988-06-07 DD DD88326850A patent/DD280323A5/de not_active IP Right Cessation
- 1988-06-07 CS CS392488A patent/CS274628B2/cs not_active IP Right Cessation
- 1988-06-07 DD DD88316492A patent/DD281600A5/de not_active IP Right Cessation
- 1988-06-07 DD DD88326849A patent/DD280320A5/de not_active IP Right Cessation
- 1988-06-07 AT AT88305180T patent/ATE90347T1/de not_active IP Right Cessation
- 1988-06-07 DE DE8888305180T patent/DE3881583T2/de not_active Expired - Fee Related
- 1988-06-07 ES ES198888305180T patent/ES2040853T3/es not_active Expired - Lifetime
- 1988-06-07 EP EP88305180A patent/EP0295051B1/en not_active Expired - Lifetime
- 1988-06-07 PL PL1988272899A patent/PL157690B1/pl unknown
- 1988-06-07 CA CA000568775A patent/CA1321791C/en not_active Expired - Fee Related
- 1988-06-08 ZA ZA884075A patent/ZA884075B/xx unknown
- 1988-06-08 IL IL86660A patent/IL86660A0/xx not_active IP Right Cessation
- 1988-06-08 HU HU882971A patent/HU205108B/hu not_active IP Right Cessation
- 1988-06-08 DK DK309988A patent/DK309988A/da not_active Application Discontinuation
- 1988-06-08 YU YU111188A patent/YU46696B/sh unknown
- 1988-06-08 KR KR1019880006855A patent/KR900004698B1/ko not_active IP Right Cessation
- 1988-06-08 PT PT87669A patent/PT87669B/pt not_active IP Right Cessation
- 1988-06-08 CN CN88103507A patent/CN1024347C/zh not_active Expired - Fee Related
- 1988-06-08 SU SU884355901A patent/SU1678208A3/ru active
- 1988-06-08 AU AU17491/88A patent/AU593742B2/en not_active Ceased
- 1988-06-08 IE IE171688A patent/IE61499B1/en unknown
- 1988-06-08 NZ NZ224937A patent/NZ224937A/xx unknown
- 1988-06-08 FI FI882722A patent/FI93835C/fi not_active IP Right Cessation
- 1988-06-08 NO NO882516A patent/NO176317C/no not_active IP Right Cessation
- 1988-06-09 EG EG320/88A patent/EG18613A/xx active

Also Published As

Publication number	Publication date
FI882722A0 (fi)	1988-06-08
NZ224937A (en)	1991-01-29
ATE90347T1 (de)	1993-06-15
EP0295051A3 (en)	1989-03-22
JPH0676391B2 (ja)	1994-09-28
FI93835C (fi)	1995-06-12
SU1678208A3 (ru)	1991-09-15
KR900004698B1 (ko)	1990-07-02
IE881716L (en)	1988-12-09
FI882722A (fi)	1988-12-10
MY103573A (en)	1993-08-28
HU205108B (en)	1992-03-30
DE3881583T2 (de)	1993-09-16
PH25928A (en)	1991-12-19
YU111188A (en)	1989-12-31
PL272899A1 (en)	1989-07-10
CA1321791C (en)	1993-08-31
DK309988A (da)	1988-12-10
KR890000476A (ko)	1989-03-14
NO176317C (no)	1995-03-15
IE61499B1 (en)	1994-11-02
PT87669B (pt)	1992-09-30
CN88103507A (zh)	1988-12-28
CS392488A2 (en)	1990-08-14
EP0295051A2 (en)	1988-12-14
EP0295051B1 (en)	1993-06-09
CN1024347C (zh)	1994-04-27
NO882516L (no)	1988-12-12
EG18613A (en)	1993-08-30
DD281600A5 (de)	1990-08-15
PT87669A (pt)	1988-07-01
NO176317B (no)	1994-12-05
NO882516D0 (no)	1988-06-08
DK309988D0 (da)	1988-06-08
DD280323A5 (de)	1990-07-04
YU46696B (sh)	1994-04-05
ES2040853T3 (es)	1993-11-01
DD280320A5 (de)	1990-07-04
CS274628B2 (en)	1991-09-15
ZA884075B (en)	1990-02-28
DE3881583D1 (de)	1993-07-15
IL86660A0 (en)	1988-11-30
JPS643173A (en)	1989-01-06
AU1749188A (en)	1988-12-15
AU593742B2 (en)	1990-02-15
PL157690B1 (en)	1992-06-30

Publication	Publication Date	Title
FI93835B (fi)	1995-02-28	Menetelmä 3-(bentsotiatsol-2-yylimetyyli)-4-okso-3-H-ftaaliatsin-1-yylietikkahappojohdannaisten valmistamiseksi
FI944164A0 (fi)	1994-09-09	Etikkahapon valmistusmenetelmä
DE69119216D1 (de)	1996-06-05	Enzymatisches Verfahren zur Herstellung von 7-Aminocephalosporinsäure und Derivate
NO166238C (no)	1991-06-19	Fremgangsmaate for konvertering av et dinitril ved hjelp av et enzym.
FI890723A0 (fi)	1989-02-15	Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
ES2052511T3 (es)	1994-07-16	Acidos 4-halogeno-2-oxiimino-3-oxobutiricos.
ATE63337T1 (de)	1991-05-15	Verfahren zur enzymatischen trennung von optisch aktiven isomeren des 2-aminobutanols.
AU605754B2 (en)	1991-01-24	Process for acylating amines with 2-benzothiazolyl thioesters of carboxylic acids
DE68920073D1 (de)	1995-02-02	Verfahren zur Verringerung der Racemisierung auf ein Mindestmass bei der Herstellung von optisch aktiven [(Aryloxy)phenoxy]propionat-Herbiziden.
IL87429A0 (en)	1989-01-31	A process for the enzymatic preparation of optically active phosphorus-containing functional acetic acid derivatives
EP0397048A3 (de)	1991-05-02	Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester
IE883467L (en)	1989-05-20	Preparing acid anhydrides from acids
ES2038335T3 (es)	1993-07-16	Procedimiento para preparar mezclas e/z de derivados de acido 2-(biciclo(3.3.0)octan-3-iliden)-acetico con porcion predominante de e o de z.
ATE41417T1 (de)	1989-04-15	Verfahren zur herstellung von 4-halogen-2hydroxyimino-acetessigsaeureestern.
IT1155456B (it)	1987-01-28	Composti dell'acido fluorometiltio acetico e procedimento per la loro preparazione

Legal Events

Date	Code	Title	Description
1995-02-01	BB	Publication of examined application
2004-08-31	MM	Patent lapsed	Owner name: PFIZER INC.